060590 — CTC Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩125bn
Enterprise Value
KR₩145bn
Revenue
KR₩144bn

Annual balance sheet for CTC Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	14,676	7,695	24,351	24,679	19,171
Net Total Accounts Receivable
Net Total Receivables	29,087	31,963	27,811	24,824	21,865
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	74,992	70,694	89,836	84,119	73,539
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	80,305	78,965	74,992	62,081	60,895
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	177,172	168,226	186,326	165,862	153,688
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	62,498	60,156	74,658	74,316	66,186
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	100,856	83,213	92,423	90,417	84,068
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	76,316	85,013	93,903	75,444	69,620
Total Liabilities & Shareholders' Equity	177,172	168,226	186,326	165,862	153,688
Total Common Shares Outstanding